INFORMATION BY CANCER TYPE

Leukemia

Looking Ahead: What's New In CAR T-Cell Therapy for Hematologic Malignancies
BY Rebecca Bernaski
Jim Kochenderfer, M.D., lends insight to the future of CAR T-cell therapy for hematologic malignancies.
Debunking the Myths of Stem Cell Donation
BY Allie Casey
Just one person can make a difference for patients with blood cancer.
A New Chapter Begins With CML
BY Tara Haelle
Hope is growing for patients who are living with CML. 
Blincyto Improves Survival for Ph- Relapsed Acute Lymphoblastic Leukemia
BY Jason M. Broderick
In a recent study, Blincyto (blinatumomab) had longer survival rates than standard chemotherapy for certain patients with ALL. 
The Final Chemo Cycle
BY Edward McClain
As Ed completes his final chemo cycle, he loses a friend.
Vyxeos Helps More Patients With AML Proceed to Transplant
BY Silas Inman
More people with AML who were treated with Vyxeos were moved to transplant than those treated with a standard chemotherapy regimen, according to recent findings.
Inotuzumab Ozogamicin Gets Priority Review for Acute Lymphoblastic Leukemia
BY Silas Inman
Inotuzumab ozogamicin was granted a priority review designation for patients with relapsed or refractory ALL. 
Blincyto Seeks FDA Approval for Leukemia Treatment
BY Jason M. Broderick
A supplemental biologics license application was filed for Blincyto to be approved for certain patients with ALL.
The Need for Targeted Clinical Trials in ALL
BY Lisa Miller
There is a need for more targeted clinical trials for patients with ALL, since many of them have Philadelphia chromosome (Ph)-like acute lymphoblastic leukemia. 
Special Feature
Share Your Art
Talk about this article with other patients, caregivers, and advocates in the Leukemia CURE discussion group.
Search Cancer Drugs & Terms
Treatment
Information about treatment, including surgery, chemotherapy, radiation therapy, immunotherapy, and vaccine therapy
Adult Acute Lymphoblastic Leukemia Treatment (PDQ®)
Expert-reviewed information summary about the treatment of adult acute lymphoblastic leukemia.
Adult Acute Myeloid Leukemia Treatment (PDQ®)
Expert-reviewed information summary about the treatment of adult acute myeloid leukemia.
Childhood Acute Lymphoblastic Leukemia Treatment (PDQ®)
Expert-reviewed information summary about the treatment of childhood acute lymphoblastic leukemia.
Chronic Lymphocytic Leukemia Treatment (PDQ®)
Expert-reviewed information summary about the treatment of chronic lymphocytic leukemia.
Chronic Lymphocytic Leukemia Treatment (PDQ®)
Expert-reviewed information summary about the treatment of chronic lymphocytic leukemia.
Chronic Myelogenous Leukemia Treatment (PDQ®)
Expert-reviewed information summary about the treatment of chronic myelogenous leukemia.
Hairy Cell Leukemia Treatment (PDQ®)
Expert-reviewed information summary about the treatment of hairy cell leukemia.